Penumbra (PEN) Research & Development (2014 - 2026)
Penumbra (PEN) posted quarterly Research & Development of $25.4 million for Q2 2026, up 9.38% year-over-year from $23.2 million in Q2 2025, and up 13.47% quarter-over-quarter from $22.4 million in Q1 2026.
Penumbra (PEN) Research & Development (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Research & Development for 13 consecutive years, with $25.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Research & Development rose 9.38% year-over-year to $25.4 million; the TTM figure through Jun 2026 stood at $92.2 million (up 1.92% YoY), while the FY2025 annual figure was $89.8 million, down 5.29% from the prior year.
- Research & Development rose to $25.4 million in Q2 2026 per PEN's latest filing, from $22.4 million in the prior quarter.
- Across five years, Research & Development topped out at $25.4 million in Q2 2026 and bottomed at $18.0 million in Q4 2022.
- Historically, Research & Development has averaged $22.0 million across 5 years, with a median of $21.9 million in 2023.
- On a YoY basis, Research & Development climbed as much as 27.41% in 2022 and fell as far as 65.46% in 2022.
- Penumbra's Research & Development stood at $18.0 million in 2022, then grew by 22.14% to $21.9 million in 2023, then retreated by 8.81% to $20.0 million in 2024, then rose by 8.92% to $21.8 million in 2025, then climbed by 16.53% to $25.4 million in 2026.
- Business Quant data shows PEN's Research & Development at $25.4 million in Q2 2026, $22.4 million in Q1 2026, and $21.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Penumbra | 12.81 Bn | 12.16 Bn | 264.94 Mn | 25.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.40 Mn |
| Mar 31, 2026 | 22.38 Mn |
| Dec 31, 2025 | 21.79 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 23.22 Mn |
| Mar 31, 2025 | 22.08 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 25.21 Mn |
| Jun 30, 2024 | 24.94 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 21.94 Mn |
| Sep 30, 2023 | 20.96 Mn |
| Jun 30, 2023 | 21.54 Mn |
| Mar 31, 2023 | 19.99 Mn |
| Dec 31, 2022 | 17.96 Mn |
| Sep 30, 2022 | 21.32 Mn |
| Jun 30, 2022 | 19.56 Mn |
| Mar 31, 2022 | 20.56 Mn |
| Dec 31, 2021 | 52.00 Mn |
| Sep 30, 2021 | 16.73 Mn |